1-3 of 3
A. Skotnicki
Close
Sort by
Journal Articles

The Significance of Palifermin (Kepivance) in Reduction of Oral Mucositis (OM) Incidence and Acute Graft Versus Host Disease (aGvHD) in Patients with Hematological Diseases Undergoing HSCT.

B. Nasilowska-Adamska, P. Rzepecki, J. Manko, A. Czyz, M. Markiewicz, I. Fedorowicz, A. Tomaszewska, B. Piatkowska-Jakubas, A. Wrzesien-Kus, M. Bieniaszewska, D. Duda, K. Halaburda, A. Szczepinski, A. Lange, A. Hellman, T. Robak, A. Skotnicki, Wieslaw W. Jedrzejczak, J. Walewski, J. Holowiecki, M. Komarnicki, A. Dmoszynska, K. Warzocha, B. Marianska
Journal: Blood
Blood (2006) 108 (11): 2965.
https://doi.org/10.1182/blood.V108.11.2965.2965
Published: 2006
Journal Articles

Consolidation of Chemotherapy Response in Mantle Cell Lymphoma (MCL) Patients with 90 Y-Ibritumomab Tiuxetan ( 90 Y-Zevalin) Radioimmunotherapy (RIT).

W. Jurczak, A. Giza, D. Krochmalczyk, J. Wegrzyn, A. Hubalewska-Dydejczyk, A. Sowa-Staszczak, W. Knopinska-Posluszny, B. Zdziarska, S. Krycz-Krzemien, P. Boguradzki, L. Poplawska, A. Skotnicki
Journal: Blood
Blood (2005) 106 (11): 2453.
https://doi.org/10.1182/blood.V106.11.2453.2453
Published: 2005
Journal Articles

Manageable and Transient Hematologic Toxicity Associated with 90 Y-Ibritumomab Tiuxetan ( 90 Y-Zevalin) Consolidation of FCM Chemotherapy in Mantle Cell Lymphoma (MCL) Patients.

W. Jurczak, M. Szostek, A. Giza, Z. Rudzki, A. Skotnicki
Journal: Blood
Blood (2005) 106 (11): 4793.
https://doi.org/10.1182/blood.V106.11.4793.4793
Published: 2005